Florian Schonharting
CIK 1360509 · last filed 2026-09-09
Florian Schonharting is a corporate insider who has filed 21 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for GHRS, was dated Sep 9, 2026. Across all open-market trades the lifetime net is −$11.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $203.5M across reported positions. 38 SEC filings were submitted jointly with Public Equity K/S NB.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
QLTI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
DK-1100
COPENHAGEN, G7 G7
Holdings By Company
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-09 | GHRS | Grant (A) | — | $0 | EDGAR |
| 2012-05-18 | QLTI | Buy (P) | +100,000 | $666.7K | EDGAR |
| 2010-06-11 | — | Buy (P) | +1,494,532 | $750.0K | |
| 2010-04-26 | Astex Pharmaceuticals, Inc (SUPG) Delisted | Sell (S) | −807,597 | -$2.53M | EDGAR |
| 2010-03-16 | QLTI | Buy (P) | +659,067 | $3.26M | EDGAR |
| 2010-03-11 | QLTI | Buy (P) | +240,858 | $1.16M | EDGAR |
| 2010-01-12 | — | Buy (P) | +1,992,428 | $1000.0K | |
| 2010-01-11 | — | Buy (P) | +1,992,428 | $103.4K | |
| 2009-10-23 | QLTI | Sell (S) | −6,000,000 | -$19.20M | EDGAR |
| 2009-10-21 | QLTI | Sell (S) | −791,403 | -$3.14M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.